MX2016005539A - Composiciones farmaceuticas que comprenden agentes antibacterianos. - Google Patents

Composiciones farmaceuticas que comprenden agentes antibacterianos.

Info

Publication number
MX2016005539A
MX2016005539A MX2016005539A MX2016005539A MX2016005539A MX 2016005539 A MX2016005539 A MX 2016005539A MX 2016005539 A MX2016005539 A MX 2016005539A MX 2016005539 A MX2016005539 A MX 2016005539A MX 2016005539 A MX2016005539 A MX 2016005539A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
antibacterial agents
pharmaceutically acceptable
acceptable derivative
sulbactam
Prior art date
Application number
MX2016005539A
Other languages
English (en)
Spanish (es)
Inventor
Bhagwat Sachin
Vithalbhai Patel Mahesh
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2016005539A publication Critical patent/MX2016005539A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2016005539A 2013-10-30 2014-10-22 Composiciones farmaceuticas que comprenden agentes antibacterianos. MX2016005539A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/065523 WO2015063653A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
IN3422MU2013 IN2013MU03422A (enExample) 2013-10-30 2014-10-22

Publications (1)

Publication Number Publication Date
MX2016005539A true MX2016005539A (es) 2016-10-03

Family

ID=52003013

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005539A MX2016005539A (es) 2013-10-30 2014-10-22 Composiciones farmaceuticas que comprenden agentes antibacterianos.

Country Status (10)

Country Link
US (1) US20160287571A1 (enExample)
EP (1) EP3062793A1 (enExample)
JP (1) JP2016535038A (enExample)
CN (1) CN106163519A (enExample)
AU (1) AU2014343327A1 (enExample)
CA (1) CA2928368A1 (enExample)
IN (1) IN2013MU03422A (enExample)
MX (1) MX2016005539A (enExample)
RU (1) RU2016115375A (enExample)
WO (1) WO2015063653A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016151543A1 (en) * 2015-03-25 2016-09-29 Wockhardt Limited Pharmaceutical compositions comprising antibacterial agents
US11180501B2 (en) 2017-12-01 2021-11-23 Qilu Pharmaceutical Co., Ltd. Crystal form of β-lactamase inhibitor and preparation method therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013028813B1 (pt) * 2011-08-27 2020-10-20 Wockhardt Limited derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e composições farmacêuticas que os compreendem

Also Published As

Publication number Publication date
CA2928368A1 (en) 2015-05-07
EP3062793A1 (en) 2016-09-07
CN106163519A (zh) 2016-11-23
RU2016115375A3 (enExample) 2018-07-18
JP2016535038A (ja) 2016-11-10
RU2016115375A (ru) 2017-12-01
WO2015063653A1 (en) 2015-05-07
AU2014343327A1 (en) 2016-05-12
IN2013MU03422A (enExample) 2015-07-17
US20160287571A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
MY195977A (en) Heterocyclic Compounds and uses Thereof
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
MX2016016593A (es) Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos.
MY197698A (en) Oxysterols and methods of use thereof
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2015DN00598A (enExample)
MY181898A (en) Heterocyclic compounds and uses thereof
MX2018014813A (es) Composiciones antibacterianas.
MY162886A (en) Novel tetrahydropyridopyrimidine compound or salt thereof
MX2015015562A (es) Dihidropiridinona como inhibidores de monoacilglicerol aciltransferasa 2.
MX2016001138A (es) Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
IN2013MU01985A (enExample)
MY188169A (en) Pharmaceutical compositions and use thereof
MX2016005160A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2014MU00859A (enExample)
IN2013MU03704A (enExample)
IN2013MU03422A (enExample)
NZ719215A (en) Pharmaceutical compositions comprising antibacterial agents
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2013MU03421A (enExample)
IN2013MU03565A (enExample)
MX2017010992A (es) Composiciones farmaceuticas estables que comprenden agente antibacteriano.